Answers are grounded in this paper and cite their sources.
MEKK3/MAP3K3 links experimentally defined receptor, scaffold and endothelial mechanisms that could influence spinal cord injury (SCI), but their relevance depends on the initiating lesion and the intervention tested. This critical narrative Review separates mechanical traumatic SCI from spinal cord ischemia–reperfusion (SCIR) and compares MEKK3 with related MAP3Ks. We audit the experimental attributes of 19 selected published primary studies and retain author-reported quantitative observations with their assay conditions and sampling units. The only spinal injury intervention study in this collection concerns SCIR; it combines direct MEKK3 knockdown in cultured cells with an upstream miRNA intervention in animals. Published comparisons identify preferential p62 binding by MEKK3 relative to MEKK2, stimulus-dependent inflammatory requirements, and distinct roles for mitochondrial clearance and mitochondrial signaling. Vascular experiments distinguish loss of a physiological MEKK3 function from release of cerebral cavernous malformation (CCM)-complex restraint. Drug studies further separate changes in lesion size from lesion number and prevention from treatment of established disease. These comparisons explain why a shared downstream marker or beneficial drug response cannot independently identify MEKK3 as the causal target. The synthesis supplies a traceable account of what the published experiments resolve and derives focused questions for myeloid, mitochondrial and endothelial responses after spinal trauma. MEKK3-specific therapeutic efficacy in mechanical SCI remains unestablished.
No takes yet. Share an insight, caveat, or question.
Yuan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: